These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

814 related items for PubMed ID: 30029370

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Thiol Groups as a Biomarker for the Diagnosis and Prognosis of Prostate Cancer.
    Koike A, Robles BEF, da Silva Bonacini AG, de Alcantara CC, Reiche EMV, Dichi I, Maes M, Cecchini R, Simão ANC.
    Sci Rep; 2020 Jun 04; 10(1):9093. PubMed ID: 32499542
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. [PSA and hK2 in the diagnosis of prostate cancer].
    Alapont Alacreu JM, Navarro Rosales S, Budía Alba A, España Furió F, Morera Martínez F, Jiménez Cruz JF.
    Actas Urol Esp; 2008 Jun 04; 32(6):575-88. PubMed ID: 18655340
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. PSA-PSMA profiles and their impact on sera PSA levels and angiogenic activity in hyperplasia and human prostate cancer.
    Ben Jemaa A, Bouraoui Y, Sallami S, Banasr A, Nouira Y, Oueslati R.
    Pathol Biol (Paris); 2014 Jun 04; 62(3):129-36. PubMed ID: 24745345
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.
    Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z, Wright GL.
    Cancer Res; 2002 Jul 01; 62(13):3609-14. PubMed ID: 12097261
    [Abstract] [Full Text] [Related]

  • 55. SERS-Based Immunoassay Enhanced with Silver Probe for Selective Separation and Detection of Alzheimer's Disease Biomarkers.
    Yu D, Yin Q, Wang J, Yang J, Chen Z, Gao Z, Huang Q, Li S.
    Int J Nanomedicine; 2021 Jul 01; 16():1901-1911. PubMed ID: 33707945
    [Abstract] [Full Text] [Related]

  • 56. Tumor-associated forms of prostate specific antigen improve the discrimination of prostate cancer from benign disease.
    Mikolajczyk SD, Rittenhouse HG.
    Rinsho Byori; 2004 Mar 01; 52(3):223-30. PubMed ID: 15137320
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Au-Ag assembled on silica nanoprobes for visual semiquantitative detection of prostate-specific antigen.
    Kim HM, Kim J, An J, Bock S, Pham XH, Huynh KH, Choi Y, Hahm E, Song H, Kim JW, Rho WY, Jeong DH, Lee HY, Lee S, Jun BH.
    J Nanobiotechnology; 2021 Mar 12; 19(1):73. PubMed ID: 33712008
    [Abstract] [Full Text] [Related]

  • 59. Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers.
    Tsoi TH, Chan CF, Chan WL, Chiu KF, Wong WT, Ng CF, Wong KL.
    PLoS One; 2016 Mar 12; 11(9):e0162217. PubMed ID: 27598335
    [Abstract] [Full Text] [Related]

  • 60. Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio.
    Kaynar M, Yildirim ME, Gul M, Kilic O, Ceylan K, Goktas S.
    Cancer Biomark; 2015 Mar 12; 15(3):317-23. PubMed ID: 25586096
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.